Viscira, a leading provider of digital marketing solutions and software products for the life sciences industry, today announced that the Academy of Interactive and Visual Arts has selected Viscira as a Silver winner for the company's 3D animation video program about idiopathic pulmonary fibrosis (IPF). The award was given in the area of video/film in pharmaceuticals within the specialty category of animation use. With more than 4,000 entries from across the US and around the world, the Davey Awards honor the finest creative work from the best small firms, agencies and companies worldwide.
IPF is a chronic and ultimately fatal respiratory disease characterized by a progressive decline in lung function. The primary objective of the animation video program developed for Roche was to educate healthcare professionals on the mechanism of disease (MOD) and to highlight the human impact of the condition on patients with IPF. The video was initially deployed at the ERS (European Respiratory Society) International Conference in September 2015 in Amsterdam.
This interactive MOD animation highlights the pathological features of IPF and includes high-quality character animation. The piece was highly cinematic, creatively unique and scientifically accurate. Hagop (Kane) Kaneboughazian, VP of Animation at Viscira, described the video in short as "Toy Story meets pharma."
The Davey Awards is in its 12th season and is overseen and sanctioned by the Academy of Interactive and Visual Arts, an invitation-only body consisting of top-tier professionals from a "Who’s Who" of acclaimed media, communications, advertising, creative and marketing firms. AIVA members include executives from organizations such as Conde Nast, Disney, GE, Keller Crescent, Microsoft, Monster.com, MTV, Push, Publicis, Sesame Workshops, The Marketing Store, Worktank and Yahoo!
James Rouse, Roche’s International Product Manager - IPF, commented on the animation video. "Working with Viscira to produce this animation has been a great experience, and [the video] really helped attendees at the Congress to visualize how IPF progresses in the lungs."